C4X Discovery Sells Substance Use Treatment Rights to Indivior for GBP16 Mln
By Elena Vardon C4X Discovery Holdings on Tuesday said it is selling the proprietary rights to its oral Orexin-1 receptor antagonist for substance use...
Source: marketwatch.com